Statement of Changes in Beneficial Ownership (4)
January 03 2022 - 04:29PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5
obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL
OWNERSHIP OF SECURITIES
|
OMB
APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5 |
|
Filed pursuant to Section 16(a) of the
Securities Exchange Act of 1934 or Section 30(h) of the Investment
Company Act of 1940
|
|
| 1. Name
and Address of Reporting Person * KOSKI ROBERT
C |
2. Issuer Name and Ticker or Trading
Symbol ORAGENICS INC [ OGEN ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)__X__
Director _____
10% Owner
_____ Officer (give title
below) _____ Other
(specify below)
|
|
(Last)
(First)
(Middle)
4902 EISENHOWER BOULEVARD |
3. Date of Earliest Transaction (MM/DD/YYYY)
12/30/2021
|
|
(Street)
TAMPA, FL 33634
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or
Beneficially Owned
|
1.Title of Security
(Instr. 3) |
2. Trans. Date |
2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following
Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4) |
7. Nature of Indirect Beneficial Ownership (Instr.
4) |
|
Code |
V |
Amount |
(A) or (D) |
Price |
|
Common Stock |
12/30/2021 |
|
P |
|
200900 |
A |
$.4498 (1) |
977383 |
I |
See Footnote (3) |
|
Common Stock |
12/31/2021 |
|
P |
|
799100 |
A |
$.4740 (2) |
1776483 |
I |
See Footnote (3) |
|
Common Stock |
|
|
|
|
|
|
|
212839 |
D |
|
|
Common Stock |
|
|
|
|
|
|
|
53086 |
I |
See Footnote (4) |
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible
securities)
|
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative
Security |
3. Trans. Date |
3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or
Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying
Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially
Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct
(D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr.
4) |
|
Code |
V |
(A) |
(D) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
| Explanation of
Responses: |
| (1) |
The price reported in Column
4 is a weighted average price. These shares were purchased in
multiple transactions ranging from $0.43 to $0.46. The reporting
person undertakes to provide the issuer, any security holder of the
issuer, or the staff of the Securities and Exchange Commission,
upon request, full information regarding the number of shares
purchased at each separate price within the range set forth
above. |
| (2) |
The price reported in Column
4 is a weighted average price. These shares were purchased in
multiple transactions ranging from $0.44 to $0.48. |
| (3) |
Represents shares owned by
the Koski Family Limited Partnership ("KFLP"). The reporting person
serves as one of the general partners of the KFLP and disclaims
beneficial ownership of the securities reflected as held by the
KFLP except to the extent of the reporting person's pecuniary
interest therein and this report shall not be deemed an admission
that the reporting person is the beneficial owner for purposes of
Section 16 or any other purpose. |
| (4) |
Shares owned by trusts of
which Mr. Robert C. Koski is sole trustee. Such trusts are as
follows: the Robert Clayton Koski Trust for the benefit of Anthony
James Hunter (10,760 shares); the Robert Clayton Koski Trust for
the benefit of Hunter Buchanan Koski (10,760 shares); the Robert
Clayton Koski Trust for the benefit of Clayton Ward Bennett (10,000
shares); the Robert Clayton Koski Trust for the benefit of Robert
Edward Koski (10,760 shares); and the Robert Clayton Koski Trust
for the benefit of Elyse Margaux Koski (10,806 shares). Mr. Koski
disclaims beneficial ownership of the shares held by the trusts
except to the extent of any pecuniary interest. |
Reporting
Owners
|
|
Reporting Owner Name / Address |
Relationships
|
|
Director |
10% Owner |
Officer |
Other |
KOSKI ROBERT C
4902 EISENHOWER BOULEVARD
TAMPA, FL 33634 |
X |
|
|
|
Signatures
|
|
/s/ Mark A. Catchur, as Attorney-in-Fact for
ROBERT C. KOSKI |
|
1/3/2022 |
| **Signature of
Reporting Person |
Date |
Oragenics (AMEX:OGEN)
Historical Stock Chart
From May 2022 to Jun 2022
Oragenics (AMEX:OGEN)
Historical Stock Chart
From Jun 2021 to Jun 2022
